A significant advance in cancer research is occurring with the use of mini-antibodies to reactivate mutated p53. This vital malignant protector protein is frequently lost in many kinds of malignancies, causing https://bookmark-media.com/story22077467/nanobodies-revive-the-p53-protein-new-new-pathway-for-malignant-therapy